LYNCHNOW™ is a comprehensive screening that rapidly detects mutations that causes Lynch syndrome, along with saving unnecessary costs to those cost for individuals.
The protocol, which is largely accepted throughout the medical field, consists of first screening for DNA mismatch repair (MMR) proteins MLH1, MSH2, MSH6, and PMS2 by way of immunohistochemistry. This process gives results within 3 to 5 days and allows the clinician to make a rapid decision on the next step.
Lynch syndrome is an inherited condition that increases your risk of developing colon cancer and other cancers associated with this syndrome. Lynch syndrome is hereditary, which means it is caused by genetic changes that can be passed from parents to their children. Those with Lynch syndrome are much more likely to develop cancers associated with this syndrome at a younger age (before 50). Also, women with Lynch syndrome are much more likely than the general population to develop endometrial (uterine) cancer.
Lynch syndrome, often called Hereditary Nonpolyposis Colorectal Cancer (HNPCC), affects both men and women. It increases the risk of several cancers, particularly cancers of the colon (large intestine) and rectum.
Part of LYNCHNOW™ includes genetic counseling to walk you through our process and test results, along with any lifestyle or treatment alternatives depending on your results.
